<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00511498</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00001428</org_study_id>
    <nct_id>NCT00511498</nct_id>
  </id_info>
  <brief_title>Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical Prostatectomy</brief_title>
  <official_title>Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Nerve-Sparing Laparoscopic Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ability of sildenafil to aid in the return of erections after nerve-sparing radical
      prostatectomy has been established. Patients who had either one or both neurovascular bundles
      spared demonstrated dramatically better responses to &quot;as needed&quot; sildenafil than those that
      did not, and a positive erectile response to sildenafil was only seen in patients in whom at
      least one NVB was spared. This study has been designed to determine if sildenafil taken
      nightly works better than sildenafil on as &quot;as needed&quot; basis for the return of erectile
      function. The investigators hypothesis is that sildenafil taken nightly promotes a more rapid
      return of erectile function after nerve-sparing laparoscopic radical prostatectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IIEF score</measure>
    <time_frame>13 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Placebo Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo nightly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sildenafil 50mg nightly</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil</intervention_name>
    <description>50 mg daily at bedtime</description>
    <arm_group_label>Placebo Arm</arm_group_label>
    <arm_group_label>Drug</arm_group_label>
    <other_name>Viagra</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male sex

          2. Age &lt; 65

          3. IIEF erectile function domain score &gt; 26 (out of 30 points possible for this subscale)

          4. Steady sexual partner

          5. Untreated prostate cancer TNM stage &lt; cT2bNxMx (cT1a, cT1b, cT1c, cT2a) and Gleason
             grade &lt; 8.

          6. Willingness to participate in a clinical trial as manifested by informed consent

          7. Actually undergo nerve-sparing LRP surgery

        Exclusion Criteria:

          1. Not fulfilling all of the criteria for entry above

          2. Any prior prostate cancer treatment (radiation, hormonal deprivation, chemotherapy)

          3. Contraindication to sildenafil (e.g. nitrates, hypersensitivity)

          4. Existing PDE5 inhibitor requirement for functional erection (e.g. for intercourse)
             preoperatively

          5. Obstructive sleep apnea
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian P Pavlovich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2007</study_first_submitted>
  <study_first_submitted_qc>August 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2007</study_first_posted>
  <last_update_submitted>November 28, 2008</last_update_submitted>
  <last_update_submitted_qc>November 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2008</last_update_posted>
  <responsible_party>
    <name_title>Christian Pavlovich, M.D.</name_title>
    <organization>Johns Hopkins University</organization>
  </responsible_party>
  <keyword>Laparoscopic Radical Prostatectomy</keyword>
  <keyword>Nightly sildenafil</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

